Compare ACN & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACN | MDT |
|---|---|---|
| Founded | 1989 | 1949 |
| Country | Ireland | Ireland |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.2B | 131.9B |
| IPO Year | 2015 | 2014 |
| Metric | ACN | MDT |
|---|---|---|
| Price | $193.71 | $87.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 20 |
| Target Price | ★ $270.81 | $109.89 |
| AVG Volume (30 Days) | 5.4M | ★ 6.9M |
| Earning Date | 03-19-2026 | 06-03-2026 |
| Dividend Yield | ★ 3.42% | 3.22% |
| EPS Growth | 6.21 | ★ 30.80 |
| EPS | ★ 6.47 | 2.76 |
| Revenue | ★ $69,672,977,000.00 | $33,537,000,000.00 |
| Revenue This Year | $7.44 | $8.91 |
| Revenue Next Year | $5.36 | $6.77 |
| P/E Ratio | ★ $29.40 | $31.89 |
| Revenue Growth | ★ 7.36 | 3.62 |
| 52 Week Low | $177.50 | $79.93 |
| 52 Week High | $322.86 | $106.33 |
| Indicator | ACN | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 42.40 |
| Support Level | $187.86 | $85.35 |
| Resistance Level | $205.07 | $89.01 |
| Average True Range (ATR) | 6.53 | 1.56 |
| MACD | 0.64 | 0.50 |
| Stochastic Oscillator | 66.42 | 52.00 |
Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.